The global single-use bioprocessing market is projected to reach USD 5.44 Billion by 2021 from USD 2.47 Billion in 2016, at a CAGR of 17.8% from 2016 to 2021.

In this report, the global market is broadly segmented by product, application, end user, and region. The global market is segmented on the basis of products, applications, end users, and regions. By type of product, the market is categorized into media bags and containers, filtration assemblies, single-use bioreactors, disposable mixers, and others (tubing, connectors, and samplers). The media bags and containers segment is expected to account for the largest share of the single-use bioprocessing products market in 2016. This large share can be attributed to the increasing adoption of media bags and containers in transportation and storage application.

Based on application, the market is segmented into filtration, storage, cell culture, mixing, and purification. The filtration application segment is expected to account for the largest share of the single-use bioprocessing application market in 2016. This large share can be attributed to the increasing adoption of single-use tangential flow filters, depth filters, and chromatography columns in the process development.

On the basis of end users, the market is classified into life science R&D and biopharmaceutical manufacturers. Biopharmaceutical manufacturers are the major end user of the market in 2016.

Growth of this market is propelled by the increasing demand for biopharmaceuticals, high energy efficiency, low water usage, less floor space requirement, very low risk of product cross contamination, and faster to implement are the key drivers for the growth of the global single use bioprocessing market. Emerging markets such as Brazil, China, and India provide new growth opportunities to players in the single-use bioprocessing market. On the other hand, extractability and leachability issues regarding disposable components like plastic bags, and environmental and economic concerns are the major factors that are restraining the growth of the single use bioprocessing market. In addition, the waste disposal of single-use processes and scaling-up issues are key market challenges.

The single-use bioprocessing market is dominated by established players such as Thermo Fisher Scienctific (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), and Merck Milipore (Germany).

Stakeholders

Vendors/Service Providers

Research and Consulting Firms

Research Institutions

Biopharmaceutical Manufacturers

Contract Manufacturers

Contract Research Organizations (CROs)

Contract Manufacturing Organizations (CMOs)

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

The market study doesn�t cover the market size in terms of volume

Some companies in this market are privately owned and their revenues are not available in the public domain. Hence, revenue for those companies are not included in this report

Company developments not reported in the public domain are not included in this report

Particular Scope Region North America (U.S. and Canada)

Europe

Asia-Pacific (China, India. And Japan)

RoW Historical Years 2014 Base Year 2015 Estimated Year 2016-e Forecast Period 2016-e�2021-p Revenue Currency USD ($)

Market Segmentation

This research report categorizes the single-use bioprocessing market on the basis of products, applications, end users, and regions.

Single-use Bioprocessing Market, by Product

Media Bags and Containers

Filtration Assemblies

Single-use Bioreactors

Disposable Mixers

Others (Tubing, Connectors, and Samplers)

Single-use Bioprocessing Market, by End User

Life Science R&D

Biopharmaceutical Manufacturers

Single-use Bioprocessing Market, by Application

Filtration

Storage

Cell Culture

Mixing

Purification

Single-use Bioprocessing Market, by Region

North America U.S. Canada

Europe

Asia-Pacific China India Japan Rest of Asia (RoAPAC)

Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs. The following customization options are available for the report:

Geographical Analysis

Further breakdown of the Europe single use bioprocessing market into Germany, U.K., France, and RoE

Company Information

Detailed analysis and profiling of additional market players (Up to 5)

Market by volume

The global single-use bioprocessing market is poised to reach USD 5.44 Billion by 2021 from USD 2.47 Billion in 2016, at a CAGR of 17.8% from 2016 to 2021. In this report, the global market is broadly segmented by product, application, end user, and region.

Major factors fueling market growth are the increasing demand for biopharmaceuticals, high energy efficiency, low water usage, less floor space requirement, very low risk of product cross contamination, and faster to implement are the key drivers for the growth of the global single use bioprocessing market. On the other hand, extractability and leachability issues regarding disposable components like plastic bags, and environmental and economic concerns are the major factors that are restraining the growth of the single use bioprocessing market.

By type of product, the market is categorized into media bags and containers, filtration assemblies, single-use bioreactors, disposable mixers, and others (tubing, connectors, and samplers). The media bags and containers segment is expected to account for the largest share of the single-use bioprocessing products market in 2016. This large share can be attributed to the increasing adoption of media bags and containers in transportation and storage application.

Furthermore, on the basis of application the market is segmented into filtration, storage, cell culture, mixing, and purification. The filtration application segment is expected to account for the largest share of the single-use bioprocessing application market in 2016. This large share can be attributed to the increasing adoption of single-use tangential flow filters, depth filters, and chromatography columns in the process development.

On the basis of end users, the market is classified into life science R&D and biopharmaceutical manufacturers. Biopharmaceutical manufacturers are the major end user of the market in 2016.

North America is established markets for single-use systems. Increasing demand for the biopharmaceuticals especially from in the aging population, increase growth in R&D investments by biopharmaceutical companies, and patent expiries of biologics are the key drivers for the North American single-use bioprocessing market. Compared to mature markets, the Asia-Pacific region is expected to grow at the highest rate from 2016 to 2021. Growth in this region is propelled by factors such as improving R&D infrastructure, rising focus of market players, and increasing government initiatives.

The Single-use Bioprocessing Market is dominated by established players such as Thermo Fisher Scienctific (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), and Merck Milipore (Germany).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst